Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Microsoft stock ends higher as software selloff deepens; traders weigh Azure outages and AI spend

Microsoft stock ends higher as software selloff deepens; traders weigh Azure outages and AI spend

Microsoft shares closed up 0.6% at $413.56 Wednesday, outperforming a sharp sell-off in software stocks. Short interest in Microsoft rose about 20% over the past week, and options activity stayed defensive. Traders watched for fallout from a multi-region Azure outage linked to a storage policy change. Key U.S. economic data releases were delayed after a brief government shutdown.
CrowdStrike stock slides as insider sale filings hit the tape ahead of earnings

CrowdStrike stock slides as insider sale filings hit the tape ahead of earnings

CrowdStrike shares fell 1.8% to $414.00 Wednesday after CEO George Kurtz and CFO Burt Podbere disclosed stock sales tied to vested RSUs, according to SEC filings. Kurtz sold 6,777 shares and filed to sell more, while Podbere sold 1,630 shares. The moves come as investors await CrowdStrike’s quarterly report due March 3. Broader tech stocks showed mixed performance amid ongoing concerns over AI’s impact on software.
RTX stock slips despite Pentagon missile ramp-up deal — what investors watch next

RTX stock slips despite Pentagon missile ramp-up deal — what investors watch next

RTX Corp shares fell about 3% to $197.33 Wednesday after announcing a seven-year Pentagon deal to sharply boost missile production. The drop followed four days of gains and came amid heavy trading. Vietjet Air ordered Pratt & Whitney engines for 44 more Airbus jets, with deliveries starting in July. RTX also committed over $139 million to expand manufacturing and maintenance in Singapore.
Confluent stock price today: CFLT stays just under IBM’s $31 offer as February deadlines near

Confluent stock price today: CFLT stays just under IBM’s $31 offer as February deadlines near

Confluent shares traded at $30.42 Wednesday, about 2% below IBM’s $31-per-share cash offer, as investors await a February 12 shareholder vote on the $11 billion deal. The U.S. antitrust waiting period expired January 12, but the merger still needs shareholder and further regulatory approval. Confluent will report earnings February 11 without a call or outlook. Trading volume surged to 53 million shares ahead of key dates.
Why Wells Fargo stock (WFC) is up today as the yield curve steepens — the next catalyst to watch

Why Wells Fargo stock (WFC) is up today as the yield curve steepens — the next catalyst to watch

Wells Fargo shares rose 1.2% to $93.44 by midafternoon Wednesday as U.S. bank stocks gained alongside a steeper Treasury yield curve. The KBW Nasdaq Bank Index advanced 1.23%. Wells Fargo priced 5.50% fixed-rate callable notes due 2046, per an SEC filing. The bank projects $50 billion in net interest income for 2026 and reported $612 million in severance costs tied to layoffs.
4 February 2026
Analog Devices stock jumps again — CEO sale filing, chip M&A and Feb. 18 earnings in focus

Analog Devices stock jumps again — CEO sale filing, chip M&A and Feb. 18 earnings in focus

Analog Devices shares rose 3.3% to $321.46 Wednesday afternoon, rebounding after Tuesday’s drop. The move followed Texas Instruments’ $7.5 billion deal to acquire Silicon Labs, which reignited M&A speculation in analog chips. CEO Vincent Roche sold 10,000 shares last week under a preset plan. Investors await Analog Devices’ earnings on Feb. 18.
Chipotle stock rebounds from early drop as CMG traders rethink 2026 outlook

Chipotle stock rebounds from early drop as CMG traders rethink 2026 outlook

Chipotle shares rebounded to $40.00, up 2.1%, after dropping to $36.50 earlier Wednesday. The company reported Q4 revenue of $3.0 billion, but comparable sales fell 2.5% and transactions dropped 3.2%. Chipotle projects flat comparable sales for 2026 and plans 1–2% menu price hikes to offset rising costs, especially for beef. Investors await further details in the upcoming SEC filing.
Marvell Technology stock slips as Celestial AI deal dilution meets a wider chip selloff

Marvell Technology stock slips as Celestial AI deal dilution meets a wider chip selloff

Marvell Technology shares fell about 2% to $74.06 Wednesday after the company closed its $1 billion acquisition of Celestial AI and warned of higher short-term costs and share dilution. Marvell issued over 24 million unregistered shares for the deal and may issue more if revenue targets are met. Investors are watching for signs of demand and integration ahead of the company’s earnings report.
Qualcomm stock price rises ahead of earnings — what QCOM investors watch after the bell

Qualcomm stock price rises ahead of earnings — what QCOM investors watch after the bell

Qualcomm shares rose 2.8% to $151.33 Wednesday afternoon ahead of its fiscal first-quarter earnings report, bucking a 3.6% drop in the iShares Semiconductor ETF. Wall Street expects $12.13 billion in revenue and $3.39 adjusted EPS for the December quarter. Trading volume in Qualcomm surpassed its 50-day average. Investors are watching for guidance on handset demand and profit margins.
AT&T stock rises on Amazon cloud-satellite tie-up as traders eye fiber rollout

AT&T stock rises on Amazon cloud-satellite tie-up as traders eye fiber rollout

AT&T shares rose 1.5% to $27.22 after announcing a deeper partnership with Amazon Web Services to move network workloads to the cloud and expand broadband via Amazon’s satellites. The move follows AT&T’s $5.75 billion acquisition of Lumen’s fiber business, adding over 1 million subscribers. Wall Street awaits cost details, with more information expected at Mobile World Congress in March.
AbbVie stock drops after Rinvoq sales miss, even as 2026 profit forecast tops estimates

AbbVie stock drops after Rinvoq sales miss, even as 2026 profit forecast tops estimates

AbbVie shares fell 2.5% to $219.98 Wednesday after Rinvoq sales missed forecasts, despite the company raising its 2026 profit outlook. Q4 adjusted earnings reached $2.71 per share on $16.618 billion revenue; Skyrizi sales rose 32.5%, while Humira dropped 25.9%. AbbVie announced a three-year Medicaid pact with the Trump administration and pledged $100 billion in U.S. investments.
AST SpaceMobile (ASTS) stock slides as AT&T taps Amazon Leo for satellite broadband

AST SpaceMobile (ASTS) stock slides as AT&T taps Amazon Leo for satellite broadband

AST SpaceMobile shares fell 10% to $103.73 after AT&T announced a new satellite broadband partnership with AWS and Amazon Leo, focused on business customers. Trading volume topped 15.9 million shares. The drop followed investor concerns over AT&T’s commitment to AST’s direct-to-phone satellite plans. AST’s next satellite launch is scheduled for late February.
4 February 2026
NXP stock rebounds in regular trade as CEO pitches ‘physical AI’ after earnings whipsaw

NXP stock rebounds in regular trade as CEO pitches ‘physical AI’ after earnings whipsaw

NXP Semiconductors shares rose about 2% Wednesday to $225.03, rebounding after a 4.5% drop the previous session. The move followed a first-quarter revenue forecast of $3.05–$3.25 billion, above analyst expectations. CEO Rafael Sotomayor cited “physical AI” as a growth driver for industrial chips. BofA Securities cut its price target to $245 but maintained a buy rating.
TransDigm (TDG) stock falls again as Baird downgrade keeps pressure on share price

TransDigm (TDG) stock falls again as Baird downgrade keeps pressure on share price

TransDigm shares fell 2.3% to $1,271.89 Wednesday after Baird downgraded the stock and cut its price target to $1,400. The company reported a 14% rise in net sales to $2.285 billion for the fiscal first quarter, but net income dropped nearly 10% to $445 million due to higher interest expenses. TransDigm raised its 2026 profit forecast but kept the midpoint below analyst expectations.
4 February 2026
Boston Scientific stock price skids as key heart-rhythm sales miss jolts BSX

Boston Scientific stock price skids as key heart-rhythm sales miss jolts BSX

Boston Scientific shares fell 15% to $77.83 after quarterly electrophysiology sales missed Wall Street estimates, with Q4 revenue in that segment at $890 million versus a $933 million consensus. Analysts flagged fresh doubts about growth in electrophysiology and Watchman devices. The stock’s drop marked its sharpest one-day decline in over 25 years. Investors await Watchman “CHAMPION” trial data at the ACC.26 meeting in March.
4 February 2026
Eaton (ETN) stock slips after cautious 2026 outlook — here’s what investors are watching

Eaton (ETN) stock slips after cautious 2026 outlook — here’s what investors are watching

Eaton shares fell 0.9% to $359.17 Wednesday after the company’s 2026 profit forecast missed Wall Street estimates. Data-center orders in Electrical Americas surged 200% in Q4, but first-quarter margin guidance came in below expectations. Management confirmed plans to spin off the mobility business. Fourth-quarter adjusted EPS reached a record $3.33 on $7.1 billion in sales.
1 31 32 33 34 35 613

Stock Market Today

RELX share price slides again on AI worries; what to watch ahead of Feb 12 results

RELX share price slides again on AI worries; what to watch ahead of Feb 12 results

8 February 2026
RELX shares fell 4.6% to 2,145p on Friday, near a 52-week low, despite the FTSE 100 closing higher. The company disclosed a new buyback of 465,361 shares on Feb. 6 and has repurchased over 8.8 million shares since Jan. 2. Investors await RELX’s full-year 2025 results on Feb. 12 amid concerns over AI’s impact on its core business.
Glencore shares steady after Rio walks away — what to watch before Monday’s trade

Glencore shares steady after Rio walks away — what to watch before Monday’s trade

8 February 2026
Glencore shares closed up 0.6% at 478.10 pence Friday after Rio Tinto ended merger talks, issuing a “no intention to bid” statement. Glencore’s board rejected the proposed deal terms, citing concerns over valuation and governance. Attention now turns to possible asset sales, including its $5 billion Kazzinc stake, ahead of Glencore’s annual results on Feb. 18.
Go toTop